Back
Viridian Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
VRDN
Viridian Therapeutics, Inc.
Last Price:
$28.79
Seasonality Move:
-15.82%
7 Day Trial
ALL ACCESS PASS
$
7
Viridian Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Viridian Therapeutics, Inc. has on average historically fallen by 8.7% based on the past 11 years of stock performance.
-
Viridian Therapeutics, Inc. has fallen lower in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
-
Is Viridian Therapeutics, Inc. Stock Undervalued?The current Viridian Therapeutics, Inc. [VRDN] share price is $30.07. The Score for VRDN is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
VRDN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Viridian Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Viridian Therapeutics, Inc. has on average historically fallen by 8.7% based on the past 11 years of stock performance.
Viridian Therapeutics, Inc. Stock Rating
Sell
47
Viridian Therapeutics, Inc. (VRDN)
is a Sell
Is Viridian Therapeutics, Inc. overpriced?
-
Viridian Therapeutics, Inc. has fallen lower in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
Viridian Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
viridiantherapeutics.com
52-Week Data
52-Week High:
34.29
52-Week Low:
9.90
Prediction Charts
Market Cap:
2.9B
Price in USD:
30.07
Volume:
1.8M
Beta:
1.24
Technical Analysis
SMA50:
31.84
SMA100:
28.05
SMA200:
22.06
52-Wk Change:
68.37%
Stock Predictions
-
Is Viridian Therapeutics, Inc. stock public?Yes, Viridian Therapeutics, Inc. is a publicly traded company.
-
What is the Viridian Therapeutics, Inc. stock quote today?The Viridian Therapeutics, Inc. stock price is 30.07 USD today.
-
How to buy Viridian Therapeutics, Inc. stock online?You can buy Viridian Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-23 | 32.00 | 32.93 | 33.34 | 31.37 |
| Jan-26 | 32.60 | 33.06 | 33.35 | 32.35 |
| Jan-27 | 32.65 | 33.54 | 33.65 | 32.61 |
| Jan-28 | 33.61 | 33.62 | 33.96 | 33.00 |
| Jan-29 | 33.45 | 33.57 | 34.20 | 33.00 |
| Jan-30 | 33.36 | 33.00 | 33.51 | 31.34 |
| Feb-2 | 32.72 | 33.20 | 34.18 | 32.23 |
| Feb-3 | 33.07 | 31.90 | 33.75 | 31.64 |
| Feb-4 | 31.55 | 30.37 | 31.85 | 30.08 |
| Feb-5 | 30.19 | 29.17 | 30.97 | 29.04 |
| Feb-6 | 30.14 | 29.25 | 30.17 | 28.94 |
| Feb-9 | 29.26 | 29.60 | 29.76 | 28.92 |
| Feb-10 | 29.67 | 30.06 | 30.75 | 29.56 |
| Feb-11 | 30.25 | 30.07 | 30.46 | 29.25 |
Viridian Therapeutics, Inc. Earnings
Viridian Therapeutics, Inc. Earnings Report: Per Share Viridian Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Viridian Therapeutics, Inc. Forecast Revenue Growth
Viridian Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Viridian Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and an increase next year of $1.90 per share.
* Viridian Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.